Radiotherapy has several key attributes that make it an attractive combination partner for immunotherapy; however, numerous clinical trials investigating the combination of these two treatment modalities have failed to demonstrate clear improvements in patient outcomes. In this Review, Galluzzi and colleagues...
et al. Augmented HER-2 specific immunity during treatment with trastuzumab and chemotherapy. Clin. Cancer Res. 13, 5133–5143 (2007). Article CAS PubMed Google Scholar Mitsunaga, M. et al. Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules. ...
2.1. Adoptive cellular immunotherapy (ACI) ACI refers to the treatment of killing tumor cells by injecting immunologic effector cells modified and amplified by genes, which has become a hot research direction and important means of tumor treatment because of its strong specificity, easy preservation,...
‘magic bullet’ for the treatment of cancer. The advent ofhybridoma technologyin 1975 and the development of chimeric, humanized, and human antibodies have increased the availability and utility of immunotherapy for the treatment of cancer[1]. Currently, eleven antibodies are approved for use in...
Immunotherapy treatment of cancer has progressed considerably over the past 30 years and has evolved from a general to more precisely targeted immunotherapy treatment. Examples of precision immunotherapy include checkpoint inhibitors, CAR T cells, and vaccines....
Journal for ImmunoTherapy of Cancer 2051-1426 医学1区 INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 0360-3016 医学1区 BRITISH JOURNAL OF CANCER 0007-0920 医学1区 RADIOTHERAPY AND ONCOLOGY 0167-8140 医学1区 BREAST CANCER RESEARCH 1465-5411 医学1区 ...
CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy Cancer immunotherapy has gained attention as the supreme therapeutic modality for the treatment of various malignancies. Adoptive T-cell therapy (ACT) is one of the most distinctive modalities of this therapeu... ...
Cellular immunotherapy for cancer treatment reviewedInpharma Weekly -doi:10.2165/00128413-200113170-00005NoneSpringer International PublishingInpharma Weekly
Treatment and Research CommunicationsGBR78%similarity29 Current Problems in Cancer: Case ReportsUSA78%similarity30 OncologyUSA77%similarity31 OncologyCHE77%similarity32 npj Breast CancerGBR77%similarity33 Chinese Journal of OncologyCHN76%similarity34 Journal of ImmunotherapyUSA76%similarity35 Asia-Pacific ...
treatment duration, rechallenge, and dose-ranging need attention. Advances in single-cell genomics, multiplex immunofluorescence, and multi-omic platforms encourage therapeutic discovery by finding and evaluating new immunotherapy targets. AI-based algorithms are currently being considered for radiological, ...